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1. Introduction 
1.1 Purines   
1.1.1 Structure and function of purines  
 A purine is a heterocyclic compound which consists of a pyrimidine and an imidazole 
ring (Figure 1.1). Purines play significant roles in the genetic and metabolic processes of all 
living organisms. The purine bases, adenine and guanine (shown in Figure 1.1) are 
fundamental components of nucleotides, which are the building blocks of DNA and RNA. 
Purines are also crucial components of many other biomolecules such as the energy storage 
molecule ATP, signaling molecule cAMP and the cofactor NADH. 
 
Figure 1.1 Structures of purine, adenine, guanine, ATP, cAMP and NADH. 
2  
 
 
1.1.2 Purine biosynthesis pathways 
Given the critical roles played by purines, two pathways exist for their synthesis. Purines 
can be synthesized either by the de novo pathway or the salvage pathway.  
The salvage pathway for purine synthesis is a recycling biochemical pathway in which 
the purine heterocycles created from the degradation of complex biomolecules, such as 
DNA, are reused to synthesize new purine nucleotides.
1
 Phosphoribosyltransferases are 
criticial salvage pathway enzymes which catalyze the reaction between the bases and PRPP 
(Scheme 1.1).
2
 In animals, this pathway is important for some cells which lack the enzymes 
required in the de novo pathway, such as the red blood cell.
3
 
 
Scheme 1.1 Salvage pathway of purine biosynthesis. 
 
De novo is a Latin phase meaning “from the beginning”. De novo biosynthesis refers to 
the process of complex molecule synthesis from simple starting materials. The de novo 
purine pathway begins with PRPP (shown in Figure 1.2). Glutamine donates an amino 
group to PRPP at C-1 to yield PRA. This reaction is catalyzed by the enzyme, PurF. In the 
next step glycine is added to generate GAR. After a formylation reaction, GAR is 
converted into FGAR. In the following step, glutamine provides the source of nitrogen to 
generate FGAM. Dehydration and ring closure  
3  
 
 
 
 
 
Figure 1.2 De novo purine biosynthesis pathway. 
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yields AIR. AIR is ultimately converted into CAIR by processes which differ depending on 
the organisms. Aspartic acid is then added to CAIR to yield SAICAR. In the following step, 
SAICAR is converted to AICAR, which is formylated and cyclized to yield IMP, which is 
the first ribonucleotide containing a purine ring. IMP is then converted to GMP and AMP 
to give the basic purine nucleotides. 
In general, purine synthesis is mostly conserved in all living organisms.
4
 The only 
known divergence in de novo purine biosynthesis occurs between microorganisms and 
higher eukaryotes.
5
 The difference occurs in the sixth step of the pathway (shown in figure 
1.3). In bacteria, fungi and yeast, AIR is converted into CAIR via the intermediate 
N
5
-CAIR. Two enzymes are required, namely N
5
-CAIR synthetase and N
5
-CAIR mutase.
6
 
The enzymes are also frequently referred to as PurK and Class I PurE respectively. PurK 
converts AIR, ATP and bicarbonate to N
5
-CAIR, ADP and Pi. Class I PurE transfers the 
carboxyl group of N
5
-CAIR from N-5 to C-4 of the aminoimidazole ring. In higher 
eukaryotes, AIR is directly converted to CAIR in one step by the enzyme AIR carboxylase. 
AIR carboxylase is designated as a Class II PurE. Class II PurEs utilize carbon dioxide as 
the source of the carboxyl group.
7
  
The divergence of the de novo purine biosynthesis pathways between microorganism and 
human suggests that the sixth step may be a good antimicrobial target. Inhibitors of Class I 
PurE and PurK are currently being studied as antimicrobial agents.
8
  
5  
 
 
 
Figure 1.3 Divergence at the sixth step of purine synthesis in human and microorganisms. R 
is ribose 5’-phosphate. 
 
1.1.3 Structure and function of PurK and PurE  
The crystal structures of both PurK and PurE from various organisms have been 
published (Figure 1.4).
9,10,11,12
 PurK is a functional dimer
6
 which belongs to the ATP grasp 
superfamily of enzymes.
10
 A single subunit of PurK contains three domains which are 
named the A, B and C domains.
10
 The A domain contains the AIR binding site. Conserved 
residues in the B and C domains are responsible for the binding of ATP. In functional 
studies, PurK catalyzes the activation of bicarbonate by ATP to yield carboxyphosphate. 
Then the amino group of AIR attacks either CO2 generated from carboxyphosphate or 
carboxyphosphate itself to give N
5
-CAIR.
6
  
Both Class I and Class II PurEs have been studied. The crystal structures of PurEs from 
a variety of organisms have been determined.
9,11,13
 PurE is an octamer 
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(a) 
 
(b)  
 
  
(c) 
 
Figure 1.4 Crystal structures of (a) PurE (octomer), (b) PurE (monomer) and (c) PurK 
(monomer) from E. coli. 
 
composed of eight identical subunits.
9,13
 Class II PurEs, which are designated as 
AIR carboxylases, catalyze direct conversion of AIR into CAIR. In some organisms, such 
as the yeast Cryptococcus neoformans, a bifunctional enzyme containing both PurK and 
PurE activity is created.
14
 In higher eukaryotes, like humans, the enzyme is also a 
bifunctional protein containing AIR carboxylase (Class II PurE) and SAICAR synthetase 
(PurC).
15
 In humans, this bifunctional enzyme is called PAICS 
7  
 
 
(phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole 
succinocarboxamide synthetase). Sequence alignments between Class I and Class II PurEs 
show that these enzymes are evolutionarily related to each other. However, biochemical 
studies have shown the Class I and Class II PurEs are specific for their own reaction.
14 
1.1.4 Instability of N
5
-CAIR 
N
5
-CAIR was an unknown intermediate in de novo purine biosynthesis until its discovery 
in the 1990’s, some 40 years after most of the pathway was elucidated.6 One reason for this 
is the fact that N
5
-CAIR is a primary carbamate and thus unstable (shown in Scheme 1.2). 
N
5
-CAIR has a t1/2 of ~1 min at 30°C and pH 7.8 and it is nonenzymatically converted back 
to AIR.
15
 The t1/2 of N
5
-CAIR varies depending upon pH and temperatures. The stability of 
N
5
-CAIR decreases with decreasing pH and increasing temperature.
15
 The t1/2 at pH 8.4 is 
~12 min, but at pH 7.6 is ~3 min.
6
 At 5°C the t1/2 is ~33 min. N
5
-CAIR can also be produced 
from AIR nonenzymatically.
16
 AIR and 1 M HCO3
-
 produce N
5
-CAIR so rapidly that it is 
difficult to monitor. The amount of N
5
-CAIR generated from AIR and HCO3
-
 is proportional 
to the concentration of HCO3
-
. In the presence of 1 M HCO3
-
, 75% of AIR is converted 
 
 
Scheme 1.2 Instability of N
5
-CAIR. 
to N
5
-CAIR.
16 
The instability of N
5
-CAIR creates a significant challenge for the purine biosynthetic 
8  
 
 
pathway. If the production of N
5
-CAIR is not regulated relative to its conversion to CAIR, 
ATP utilization can rapidly become non-stoichiometric. A key, unresolved question is how 
N
5
-CAIR synthesis and utilization are regulated. One method to study this is to investigate 
the system under conditions in which N
5
-CAIR stability is limited. Given the fact that 
N
5
-CAIR is unstable at higher temperatures, studying N
5
-CAIR synthesis with thermophilic 
proteins could provide insight into the problem. 
 
1.2 Thermotoga maritima 
1.2.1 Discovery and features of T. maritima 
T. maritima is a non-spore forming, rod-shaped Gram-negative bacterium, which was 
originally isolated from geothermal heated marine sediments at Vulcano, Italy, and the 
Azores.
17
 This extremely thermophilic bacterium grows between 80°C and 105°C, with an 
optimal growth temperature of 80°C.
17
 
  The genome of T. maritima has been sequenced.
18
 Both purE and purK genes, which are 
designated TM0446 and TM0447 individually, have been found in the genome sequence. 
This suggests that T. maritima follows the de novo purine biosynthetic pathway commonly 
found in microorganisms. Such a result may be unexpected given the instability of N
5
-CAIR 
noted above. 
1.2.2 Purine biosynthesis in T. maritima 
The TM0446 and TM0447 genes of T. maritima encode for N
5
-carboxyaminoimidazole 
ribonucleotide mutase (TM0446, PBD code 1O4V) and synthetase (TM0447, PBD code 
9  
 
 
3AX6) respectively.
 
The crystal structure of PurE (TM0446) shows the protein is an octamer with an inner 
channel (Figure 1.5). The closest structural homologue of TM0446 protein is PurE from E. 
coli. The residues at the active site are the same between these two PurEs. The similarity 
between TM0446 and E. coli PurE in both gene sequence and protein structure indicates that 
TM0446 may have the same catalytic activity as the standard Class I PurEs previous 
studied.  
  The structure of TM0447 was studied as well (Figure 1.5).
8
 It is a dimer and contains an 
ATP-grasp domain, indicating that TM0447 also belongs to the same superfamily as E. coli 
PurK. This provides a hint that TM0447 may have the same function as PurK from E. coli. 
While the crystal structures of these proteins have been reported, no biochemical studies 
on these proteins have been published. Thus, while the available information suggests that 
these proteins have the same activity as bacterial enzymes, no verification of this has been 
presented. 
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
(f) 
 
 
 
Figure 1.5 Crystal structures of PurE and PurK from E. coli and T. maritima. Monomer of 
PurE from E. coli (a) and T. maritima (b), monomer of PurE from E. coli (c) and T. maritima 
(d), and monomer of PurK from E. coli (e) and T. maritima (f). 
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1.3 Hypotheses 
   N
5
-CAIR is so unstable that it is readily converted back into AIR even under standard 
biochemical conditions. Under severe conditions, such as high temperature, the utilization of 
N
5
-CAIR is more troubling. The estimated t1/2 at 80°C is about 80 ms. The conversion of 
AIR into N
5
-CAIR consumes ATP. If the production of N
5
-CAIR is not regulated relative to 
its conversion to CAIR, ATP utilization can rapidly become non-stoichiometric. ATP is the 
"molecular unit of currency" of intracellular energy transfer. If more ATP molecules are 
consumed in conversion of AIR to CAIR because of the chemical instability of N
5
-CAIR, 
this would be a wasteful expense for purine synthesis. Therefore, we are interested in how 
bacteria deal with this problem. One mechanism to study this issue is to investigate how the 
problem is dealt with under conditions in which N
5
-CAIR is even more unstable. Here we 
study the functions of enzymes PurK and PurE from T. maritima, a thermophilic bacterium, 
to try to understand how these two enzymes work to control N
5
-CAIR synthesis and 
utilization at elevated temperatures. 
  Two hypotheses are proposed. One hypothesis assumes that there is a protein-protein 
interaction between PurK and PurE which allows for either direct transfer of N
5
-CAIR from 
PurK to PurE or for the regulation of N
5
-CAIR synthesis. The other one assumes PurE is 
highly efficient and thus able to convert N
5
-CAIR to CAIR before it can decompose to AIR. 
In this thesis, we will investigate the catalytic activities of both enzymes and examine the 
synthesis and utilization of N
5
-CAIR at elevated temperature and in the combination of the 
two proteins. 
12  
 
 
2. Materials and Methods 
2.1 Gene cloning 
2.1.1 PCR for purE and purK 
T. maritima PurE and PurK genes were cloned from genomic DNA from strain MSB8 
(ATCC 43589) by PCR. Each reaction mixture of a final volume of 50 µL contained 1 µM 
forward primer, 1 µM reverse primer, 1 µg template DNA, 1X Tag buffer, 1.25 U Taq, 
1.5-4.0 mM MgCl2 and 0.2 mM dNTP mix. Primers were synthesized commercially 
(Integrated DNA Technologies) (Table 2.1). The PCR was conducted for 30 cycles with each 
cycle including denaturation at 95 °C (1 min), annealing at 55 °C (1 min) and extention at 
74 °C (1 min). Products were purified by agarose gel electrophoresis and isolated from gel 
slices using a genomic DNA purification kit (Promega). 
Table 2.1 Sequences of primers for PCR. 
 
genes forward primers reverse primers 
purE (stop) 5’-AAACATATGCCAAGGGTAGGAATCATCA 5’-TTGCGGCCGCTTACTCTTTCTGGTTCAGA 
purE (non-stop) 5’-AAACATATGCCAAGGGTAGGAATCATCA 5’-TTGCGGCCGCTGCCTCTTTCTGGTTCAGA 
purK (stop) 5’-AAACATATGAAAAAGATCGGTATCATCG 5’-AAGCGGCCGCCTACCCTTGGCACATCGC 
purK (non-stop) 5’-AAACATATGAAAAAGATCGGTATCATCG 5’-AAGCGGCCGCCATCCCTTGGCACATCGC 
Underlined sequences are restriction sites: NdeI in forward primers and NotI in reverse primers. 
2.1.2 Preparation of recombinant plasmids. 
The purified purE and purK genes, which contained an A-tail, were ligated for 1 hr at 
room temperature into the pGEM-T vector (Promega) using T4 DNA ligase (Promega). 
Recombinant plasmids were transformed into E. coli DH5α and plated onto LB/X-gal for 
use in blue-white screening. Blue colonies were grown in LB medium with 100 µg/mL 
13  
 
 
ampicillin and plasmids were isolated by use of the Miniprep kit (Promega). The correct 
plasmid was verified by restriction digests using NotI and NdeI (BioLabs). 
The pGEM plasmids, pET-22b(+) and pET-28a(+) vectors (Novagen) were digested with 
NotI and NdeI at 37 °C for one hour. The digested genes and plasmids were purified by 
agarose gel electrophoresis and the genes were ligated into the plasmids. The genes ligated 
into pET-22b(+) vector generated C-terminal His-tagged proteins. The genes ligated into 
pET-28a(+) vector yielded N-terminal His-tagged proteins. Successful ligation was validated 
by restriction digest with NotI and NdeI. Plasmids were amplified and sequenced by the 
Applied Genomic Technology Center (Wayne State University) with T7 forward and T7 
reverse primers. Sequence analysis gave the expected products with no mutations. 
Expressed proteins will have the following additional sequences: HHHHHHSSGLVPRGSH 
at the N-terminus or AAALEHHHHHH at the C-terminus. 
2.2 Protein expression and purification 
  Bacteria with recombinant pET plasmids were incubated overnight in 5 mL of LB media 
at 37 °C in the presence of 100 μg/mL ampicillin (pET-22 vectors) or 100 μg/mL kanamycin 
(pET-28 vectors). The overnight culture was used to inoculate to 500 mL of LB medium 
containing the corresponding antibiotics. The culture was incubated at 37 °C until an OD600 
of 0.4 was obtained. IPTG (1 mM) was added to the medium and the incubation was 
continued for 4 hours. Bacteria were collected by centrifugation at 4000 rpm, and stored at 
-80 °C until use. 
For protein purification, bacteria were lysed using the B-PER protein extraction reagent 
14  
 
 
(Thermo). The weight of bacteria pellet was determined by a balance and 4 mL B-PER 
reagent was added for per gram of cell pellet. The suspension was incubated for 10 min at 
room temperature followed by centrifugation at 4 °C at 13,000 rpm. The supernatant was 
treated with streptomycin sulfate to a final concentration of 1% and again centrifuged at 
4 °C at 13,000 rpm to remove nucleic acids. 
  Protein purification was conducted at 4 °C. A 5 mL cobalt resin column (Gold Biotech) 
was washed with 3 mL water and 3 mL of 10 mM imidazole buffer (containing 50 mM 
sodium phosphate, 300 mM NaCl, pH 7.4) 3 times before the supernatant prepared above 
was applied to the column. The column was washed with 3 x 3 mL of 10 mM, 25 mM, 150 
mM and 400 mM imidazole containing buffer (50 mM sodium phosphate, 300 mM sodium 
chloride, pH 7.4). Fractions were collected and analyzed by 12% SDS-PAGE using 
Coomassie blue staining, which showed fractions containing 150mM and 400mM imidazole 
possessed pure protein. Fractions contained pure protein were collected and concentrated by 
dialysis centrifugal concentration (EMD). The protein was dissolved in buffer (containing 1 
mM Tris-HCl and 50 mM NaCl, pH 8.0) and concentrated several times to remove 
imidazole. The concentration of the protein was determined by Bradford assay using BSA as 
a standard. The concentrations of PurEs and PurKs ranged from 1.5 mg/mL to 14 mg/mL. 
Proteins were stored in 5 µL aliquots at -80°C. 
2.3 Thermal stability of PurE and PurK from thermophilic bacteria 
  Melting points of PurEs and PurKs from both E.coli and T. maritima were measured 
using a real-time PCR instrument (Stratagene Mx3005p, Agilent). Reactions in a final 
15  
 
 
volume of 20 µL contained 150 mM NaCl, 10 mM HEPES buffer (pH 8.0), SYPRO Orange 
and 75 µg/mL of protein. For PurE and PurK from T. maritima, melting studies were also 
conducted with 500 mM guanidine in 10 mM HEPES buffer (pH 5.0 or 8.0). Fluorescence 
of SYPRO Orange (Ex 492 nm and Em 610 nm) was determined as a function of 
temperature from 25 °C to 95 °C. Melting curves were plotted as temperature vs. 
fluorescence. Tm is determined by denaturation midpoint. 
2.4 Stability of N
5
-CAIR 
  The equilibrium of AIR to N
5
-CAIR was determined from 20 °C to 80 °C using the 
Varian UV-vis Cary 100 spectrophotometer. The equilibrium was determined in a total 
volume of 1000 µL containing 250 mM NaPO4 buffer (pH 8.0) with 200 mM sodium 
bicarbonate and 100 μM AIR. The mixture was added to a stoppered cuvette and was 
preincubated at 20 °C for 15 min. The equilibrium was monitored at 260nm as the 
temperature was ramped from 20 °C to 80 °C at a rate of 1 °C/min. The concentration of 
N
5
-CAIR was calculated using the extinction coefficient of 970 M
-1
cm
-1
.
20
  
2.5 Enzyme kinetics assay 
  Enzyme assays were conducted using the Cary 100 spectrophotometer equipped with a 
temperature controller. 
2.5.1 The activity of PurE and PurK  
2.5.1.1 CAIR decarboxylation assay for PurE from E. coli and T. maritima 
The assay for PurE was conducted in a total volume of 1000 µL containing 100 mM 
Tris-HCl buffer (pH 8.0) and PurE (10 ng) from E. coli or PurE (450 ng for 21 °C, and 
16  
 
 
200ng for both 37 °C and 50 °C) from T. maritima. The cuvette was incubated at 21, 37 or 
50 °C for 2 min, and the reaction was initiated by addition of CAIR (12.5 - 200 µM). The 
conversion of CAIR was monitored at 260 nm (Δε=8930 M-1cm-1).  
2.5.1.2 AIR carboxylation assay for PurK from T. maritima 
The assay was conducted in a final volume of 1000 µL containing 50 mM HEPES buffer 
(pH7.8), 20 mM KCl, 6.0 mM MgCl2, 1.1 mM ATP, 2.0 mM PEP, 0.2 mM NADH, 1 mM 
NaHCO3, 5 units of pyruvate kinase, 5 units of lactate dehydrogenase and PurK (500 ng). 
The cuvette was incubated at 37°C or 50°C for 2 min prior to the initiation of the reaction by 
addition of AIR (12.5-200 µM). The reaction was monitored by change in absorbance at 340 
nm. The concentration of AIR consumed was calculated using the extinction coefficient of 
6200 M
-1
cm
-1
. 
2.5.1.3 Michaelis-Menten kinetics 
  The initial velocity vs concentration of substrate was plotted to generate a 
Michaelis-Menten plot. The steady-state kinetic parameters of the enzymes were obtained 
by non-liner regression of the plot to the Michaelis-Menten equation (1). Errors reported are 
those obtained from curve fitting. 
𝑣 =
𝑣𝑚𝑎𝑥[𝑆]
𝐾𝑚+[𝑆]
  (1) 
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2.5.2 Assays of PurE and PurK in the presence of the other protein for PurE-PurK from T. 
maritima 
2.5.2.1 CAIR decarboxylation assay for PurE in the presence of PurK 
  The assay was conduted in a total volume of 1000 µL containing 100 mM Tris-HCl (pH 
8.0), PurE (100 ng) and PurK (the molar ratios of PurK/PurE monomer were 0, 0.25, 0.5, 1 
and 2). The mixture was incubated at 37°C or 50°C for 2 min and initiated by addition of 
100 µM CAIR. The reaction was monitored by change in absorbance at 260 nm. 
2.5.2.2 AIR carboxylation assay for PurK-PurE 
  The assay was conducted in a final volume of 1000 µL containing 50 mM HEPES buffer 
(pH 7.8), 20 mM KCl, 6.0 mM MgCl2, 1.1 mM ATP, 2.0 mM PEP, 0.2 mM NADH, 1 mM 
NaHCO3, 5 units of pyruvate kinase, 5 units of lactate dehydrogenase, PurK (500 ng) and 
PurK (the molar ratios of PurK/PurE monomer are 0, 0.25, 0.5, 1 and 2). The cuvette with 
the mixture was incubated at 37°C or 50°C for 2 min prior to initiation by addition of 100 
µM AIR. The reaction was monitored by change in absorbance at 340 nm. 
2.5.3 Activity of PurC from E. coli 
PurC (E. coli) was the kind gift of Dr. Kappock (Purdue University). The activity of PurC 
was determined by coupled assay monitoring ATP consumption and SAICAR production. In 
the ATP consumption assay, the assay mixture contained the following in a final volume of 
1000 µL: 50 mM HEPES buffer (pH 7.8), 20 mM KCl, 6.0 mM MgCl2, 1.1 mM ATP, 2.0 
mM PEP, 0.2 mM NADH, 5 units of pyruvate kinase, 5 units of lactate dehydrogenase, 0.1 
mM CAIR and PurC (50, 75, 100 and 125 ng). The cuvette with the mixture was 
18  
 
 
preincubated at 37°C prior to initiation by addition of 10 mM aspartic acid. The reaction 
was monitored by change in absorbance at 340 nm (Δε=6200 M-1cm-1). In the SAICAR 
production assay, the reaction contained the following in a final volume of 1000 µL: 50 mM 
HEPES buffer (pH 7.8), 20 mM KCl, 6.0 mM MgCl2, 0.1 mM ATP, 2.0 mM PEP, 5 units of 
pyruvate kinase, 5 units of lactate dehydrogenase, 0.1 mM CAIR and PurC (50 ng, 75 ng, 
100 ng and 125 ng). The reaction was monitored by change in absorbance at 282 nm 
(Δε=8480 M-1cm-1). 
2.5.4 N
5
-CAIR is the substrate for PurE 
In the PurC coupled assay, SAICAR production was monitored to determine the substrate 
of PurE (T. maritima). In the assay mixture of 1000 µL total volume, 50 mM HEPES buffer 
(pH7.8), 20mM KCl, 6.0mM MgCl2, 0.1 mM ATP, 2.0mM PEP, 5 units of pyruvate kinase, 
5 units of lactate dehydrogenase, 0.1 mM AIR, 200 ng PurE and 800ng PurC were included. 
In another reaction, 700 ng PurK was also added to the same reaction mixture described 
above. The mixture was preincubated at 37°C prior to initiation by addition of 10 mM 
aspartic acid. These reactions were monitored at 282 nm.  
2.5.5 Stoichiometry assay 
  The amounts of enzymes were calculated according to their specific activity so that the 
reaction could be completed rapidly. The reaction mixture in a total volume of 1000 µL 
contained the following: 50 mM HEPES buffer (pH7.8), 20 mM KCl, 6.0 mM MgCl2, 0.1 
mM ATP, 2.0 mM PEP, 5 units of pyruvate kinase, 17.8 µM AIR, 1000 ng or 500 ng PurE, 
2220 ng PurK and 1260 ng PurC. PurE and PurK were added in the molar ratios of 1:1 or 
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1:2. The reactions were incubated at 37°C or 50°C and initiated by addition of 10 mM 
aspartic acid. The reactions were monitored at 282 nm for SAICAR production and the 
change in the absorbance was used to calculate the amount of SAICAR produced (Δε=8480 
M
-1
cm
-1
). To determine the amount of ATP, the same assay as above was repeated expect 0.2 
mM NADH was added and ATP level was increased to 1.1 mM. The reaction was monitored 
at 340nm and the concentration of ATP was calculated from the change of absorbance 
(Δε=6200 M-1cm-1). 
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3. Results 
3.1 Gene Cloning 
Since both PurE and PurK from T. maritima had been crystalized, we initially 
attempted to express the proteins from vectors used in these studies. We were unable to 
obtain the PurK expression plasmid from the authors. For PurE, we obtained the 
recombinant plasmid pMH1 containing the purE gene fused to a 6X His-tag. The plasmid 
was transformed into E.coli LMG194 for protein expression induced by arabinose. Protein 
expression studies with various concentration of arabinose in a variety of media failed to 
generate PurE as determined by SDS-PAGE and a his-tag western blot. Attempted 
purification by a cobalt column also failed to produce the desired protein.  
Given these challenges, we elected to clone these genes ourselves. The purE and purK 
genes were cloned from genomic DNA of T. maritima by PCR (Figure 3.1). For each gene, 
we prepared two constructs. The first placed the his-tag on the N-terminus while the 
second placed the tag on the C-terminus. PCR was conducted with different 
concentrations of MgCl2 to determine the optimum concentration of magnesium. The 
optimal concentration of MgCl2 was determined to be 1.5 mM. 
The purified PCR products were ligated into the pGEM-T (Promega) vector for 
amplification. Vectors containing the purE and purK inserts were determined by 
restriction mapping (Figure 3.2). The purE and purK were removed from the vector  
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Figure 3.1 PCR products: (a) purE without stop codon, (b) purE with stop codon, (c) purK 
without stop codon and (d) purK with stop codon. M: molecular weight marker. 1-5: 1.5, 2.0, 
2.5, 3.0 and 4.0 mM magnesium chloride. 
 
 
 
Figure 3.2 Genes digested from recombinant pGEM-T vectors: (a) purE without stop codon, 
(b) purE with stop codon, (c) purK without stop codon and (d) purK with stop codon. M 
refers to standard DNA marker, 1-5 refers to plasmids isolated from different colonies. 
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by NotI and NdeI, and the inserts were gel purified and ligated into either pET-22b(+) (for 
C-terminal His-tagged proteins) or pET-28a(+) (for N-terminal His-tagged proteins) for 
protein expression. The recombinant expression plasmids were verified by restriction 
mapping (Figure 3.3) and DNA sequencing. 
 
Figure 3.3 Recombinant pET plasmids were double digested by the NotI and NdeI 
restriction enzymes to verify ligation of genes in pET vectors: (a) purE genes and (b) purK 
genes. M refers to standard DNA marker, 1-4 refers to different plasmids isolated from 
different colonies. 
 
3.2 Protein expression and purification 
The recombinant pET plasmids were transformed into BL21 DE3. A single colony was 
incubated overnight at 37 °C in 5 mL LB medium in the presence of either ampicillin or 
kanamycin. This was used to innoculate 500 mL of fresh LB medium containing ampicillin 
or kanamycin and the culture was incubated until an OD400 of 0.4 was obtained. Bacteria 
were incubated for 4 hours either in the absence or presence of 1 mM IPTG. Bacteria were 
collected by centrifuging, and stored at -80 °C until use. For purification, the bacteria were 
thawed and incubated with B-PER lysis buffer (Promega) before being applied to a 5 mL 
cobalt resin column (Gold Biotech). The column was washed with phosphate buffer 
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containing 10 mM imidazole followed by a step gradient of buffer containing 10, 25, 150 
and 400 mM imidazole. Fractions were collected and analyzed for purity by SDS-PAGE. 
Fractions containing pure protein were collected and concentrated. Imidazole was removed 
by repeated dilution and concentration. Proteins were stored in 5 μl aliquots at -80 °C. The 
purity of each protein was determined by SDS-PAGE and was judged to be at least 98% 
pure (Figure 3.4) 
 
 
 
Figure 3.4 SDS-PAGE analysis of pure protein: (a). PurE-His, (b). His-PurE, (c). PurK-His, (d). 
His-PurK. M: protein ladder. 1-6: 0.5, 1, 2, 4, 8 and 10 µg proteins. 
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3.3 Thermal stability of PurE and PurK from thermophilic bacteria. 
The thermostability of PurEs from E. coli and T. maritima were measured using a thermal 
shift assay. In this experiment, unfolded protein is detected by Sypro Orange, a fluorescent 
dye that binds to exposed hydrophobic surfaces in the denatured protein. This results in an 
increase in fluorescence as a function of protein unfolding. To promote unfolding, the 
temperature is increased. A real-time PCR instrument was used to detect the thermal melting 
of the protein. Melting curves of both PurEs are shown in Figure 3.5 a. The melting 
temperature for PurE (E.coli) in 300 mM NaCl at pH 8.0 is 72 °C. In contrast, no change in 
fluorescence intensity for PurE from T. maritima was observed under any conditions. 
Changes in pH and the addition of denaturant also failed to give a measurable melting 
temperature. These studies indicate that PurE from T. maritima is significantly more stable 
than E. coli PurE. 
The thermal stability of PurKs from E. coli and T. maritima were also measured using the 
thermal shift assay (Figure 3.5 b). The melting temperature of PurK (E. coli) in 300 mM 
NaCl at pH 8.0 is 68 °C. The changes of fluorescence intensity for PurK from T. maritima 
under all conditions tested were similar with PurE (T. maritima). These results indicate that 
the PurK from T. maritima is again remarkably more stable than E. coli PurK. 
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(a) 
 
(b)  
 
Figure 3.5 (a). Melting curves of PurE (E. coli) and PurE (T. maritima) from 25 °C to 
95 °C: A. PurE (E. coli) at pH 8, B. PurE (T. maritima) at pH 8, C. PurE (T. maritima) at pH 
5, D. PurE (T. maritima) at pH 5 in the presence of 500 mM guanidine, E. PurE (T. 
maritima) at pH 10, F. PurE (T. maritima) at pH 10 in the presence of 500 mM guanidine. 
Data from one experiment only in shown for clarity. 
(b). Melting curves of PurK (E. coli) and PurK (T. maritima) from 25 °C to 95 °C: G. PurK 
(E. coli) at pH 8, H. PurK (T. maritima) at pH 8, I. PurK (T. maritima) at pH 5, J. PurK (T. 
maritima) at pH 5 in the presence of 500 mM guanidine, K. PurK (T. maritima) at pH 10, L. 
PurK (T. maritima) at pH 10 in the presence of 500 mM guanidine. Data from one 
experiment only in shown for clarity. 
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3.4 Enzyme kinetics  
3.4.1 Activity of PurE and PurK from T. maritima. 
Although both PurE and PurK from T. maritima had been crystallized, no studies on the 
activity of these enzymes have been reported. Thus we conducted a full characterization of 
these proteins. For PurE, we examined the activity of the reverse reaction, CAIR converted 
to N
5
-CAIR, using the standard CAIR decarboxylation assay.
6
 This assay was chosen 
because of the instability of N
5
-CAIR. For PurK, we utilized the AIR carboxylation assay. 
We examined the activity of both the N and C-terminal His-tagged PurEs and PurKs at 
various temperatures (Table 3.1). For PurK, we did not examine the kinetic constant of 
bicarbonate because the equilibrium of this substrate is affected at different temperatures. 
Both the C-terminal His-tagged PurE and PurK from T. maritima showed higher Vmax and 
kcat at higher temperature, indicating that these enzymes prefer to operate at high 
temperatures. However, the effect on Km of various substrates for PurE and PurK were 
opposite. The increasing Km of CAIR for PurE at high temperature suggested that the 
temperature affected substrate binding. In contrast, the Km of AIR for PurK decreased when 
the temperature increased. The position of His-tag also affected the kcat and Km of PurE. 
N-terminal His-tagged PurE showed a lower Km and kcat, but the efficiency was roughly 
same with C-terminal His-tagged PurE. Comparing the kcat/Km value at different 
temperatures indicated that there was no big difference among the efficiency of PurEs at 
different temperatures, while PurK was more efficient as the temperature increased.  
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Table 3.1 Steady-state kinetic constants for PurE and PurK 
 
 
enzyme 
temp 
(°C) 
 
substrate 
Vmax 
(µmol/min·mg) 
kcat 
(min
-1
) 
Km 
(µM) 
kcat/Km 
(min
-1
M
-1
) 
PurE (E.coli)C
a
 37 CAIR 270±17 38200±2500 30±6.7 1.3±0.31x10
9
 
PurE (E.coli)C 50 CAIR 240±7 34000±1000 11±1.8 3.2±0.79x10
9
 
PurE (T.maritima)C
 
21 CAIR 5.2±0.2 870±30 11±2.3 0.83±0.26x10
8
 
PurE (T.maritima)C 37 CAIR 18±2 2688±367 36±8.0 0.75±0.34x10
8
 
PurE (T.maritima)C 50 CAIR 38±6 5700±900 74±17 0.78±0.38x10
8
 
PurE (T.maritima)C
c
 80
 
CAIR 69 10300 135 0.76x10
8 
PurK(T.maritima)C 21 AIR 0.8±0.1 640±40 77±13 0.83±0.23x10
7
 
PurK (T.maritima)C 37 AIR 5.2±0.1 4400±60 19±1.6 2.4±0.83x10
8
 
PurK (T.maritima)C 50 AIR 11±1 9100±680 18±0.4 5.2±2.51x10
8
 
PurK (T.maritima)C
c 
80 AIR 21 17800 18 1.2x10
9 
PurK (T.maritima)C 37 ATP 2.2±0.1 3700±100 56±5.1 0.66±0.1x10
8
 
PurK (T.maritima)C 50 ATP 4.9±0.2 8350±390 84±11 1.0±0.20x10
8
 
PurE (T.maritima)N
b 
21 CAIR 6.0±0.3 900±51 8.5±2.6 1.1±0.49x10
8
 
PurE (T.maritima)N
 
37 CAIR 13±0.3 1930±46 2.7±0.5 0.71±0.1x10
8
 
PurE (T.maritima)N
 
50 CAIR 25±1 3740±140 2.1±0.6 1.8±0.86x10
8
 
PurE (T.maritima)N
c
 80 CAIR 43 6400 2.1 3.0x10
8
 
PurK (T.maritima)N 37 AIR 2.3±0.1 3800±82 23±1.9 1.7±0.19x10
8
 
PurK (T.maritima)N 37 ATP 2.7±0.2 4600±300 50±10 0.93±0.3x10
8
 
a. C terminus 6X His-tag. b. N terminus 6X His-tag. c. Constants at 80 °C are estimated. 
 
T. maritima grows optimally at 80 °C. Attempts to investigate the activity of these 
proteins above 60 °C proved challenging due to the instability of the substrates used in the 
assay. To estimate the activity at 80 °C, we studied each enzyme at different temperatures. A 
plot of activity vs temperature gave a straight line. Thus we can estimate the activity of the 
enzymes at higher temperatures (Figure 3.6). The calculated Vmax of C-terminal His-tagged 
PurE (T. maritima) at 80 °C is 69 µmol/min·mg, kcat is 10,300 min
-1
 and Km is 135 µM. The 
estimated value of kcat/Km  
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Figure 3.6 Relationship between activity of enzymes (T. maritima) and temperature. (a) 
Vmax of PurE (T. maritima). (b) Km of PurE (T. maritima). (c) Vmax of PurK (T. maritima). 
(d) Km of PurK (T. maritima). 
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for this PurE (T. maritima) at 80 °C is 0.76x10
8 
min
-1
M
-1
. The estimated Vmax of C-terminal 
His-tagged PurK (T. maritima) at 80 °C is 21 µmol/min·mg, and kcat is 17,800 min
-1
. There 
is no linear relationship between Km and temperature for PurK. An examination of the data 
suggests that the Km at 80 °C is likely the same as that at 50 °C. Therefore the estimated 
value of kcat/Km for PurK (T. maritima) is 1.2x10
9
 min
-1
M
-1
. These estimated values indicate 
that both enzymes are highly efficient at 80 °C. 
To determine whether AIR or N
5
-CAIR is the substrate of PurE, a coupled AIR 
carboxylase assay (Scheme 3.1) was conducted with PurE (T. maritima) and PurC (E. coli) 
in the absence or presence of PurK (T. maritima).  
 
Scheme 3.1 Coupled AIR carboxylase assay with E. coli PurC. 
 
SAICAR production in the presence of PurK (T. maritima) is greater than in the absence 
of PurK (Figure 3.7). This indicates that PurK catalyzed AIR into N
5
-CAIR which is utilized 
by PurE as a substrate. Therefore, as predicted, N
5
-CAIR is the substrate for PurE. Thus, the 
PurK and PurE enzymes from T. maritima are functionally identical to these from E. coli. 
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Figure 3.7 Change of absorbance at 282 nm (for SAICAR production) from AIR catalyzed 
by PurE (T. maritima) and PurC (E. coli) in the presence and absence of PurK (T. maritima) 
at 37 °C. 
 
3.4.2 Stability of N
5
-CAIR 
  In the absence of enzymes, AIR and bicarbonate can be nonenzymatically converted into 
N
5
-CAIR in minutes or CAIR after more than 70 hours.
16
 To study the conversion of AIR 
into N
5
-CAIR at different temperatures, we conducted a thermal assay that monitored 
N
5
-CAIR production at pH 8.0 from 20 °C to 80 °C (Figure 3.8). Previous studies indicated 
that the AIR/ N
5
-CAIR equilibrium was rapidly reached and therefore we expect that the 
value represents the equilibrium value for that temperature.
16
 N
5
-CAIR was monitored at 
260 nm where the extinction coefficient of AIR (1570 M
-1
cm
-1
) is much higher than that of 
N
5
-CAIR (710 M
-1
cm
-1
). We observed that the percentage of N
5
-CAIR decreased as the 
temperature increased. This result is also consistent with previous studies which show that 
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N
5
-CAIR is more unstable at higher temperatures.
16
 These studies validate that N
5
-CAIR is 
highly unstable at 80 °C and the concentration of this intermediate in solution is very low. 
At 80 °C, only 2% of AIR is converted into N
5
-CAIR. Thus, this intermediate must be 
carefully utilized and/or stabilized. 
 
Figure 3.8 Equilibrium of AIR/HCO3
-
/N
5
-CAIR as a function of temperature.  
Data from one experiment only is shown for clarity. 
 
3.4.3 Stoichiometry 
A key question in these studies is whether at elevated temperature, the N
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-CAIR that is 
produced can be effectively utilized by the system before it is broken down to AIR. This 
would lead to a non-stoichiometric consumption of ATP. To measure this, we examined the 
stoichiometry of the PurK and PurE enzymes using the coupled PurC assay system (Table 
3.2). We measured ATP consumption using the NADH coupled system and AIR 
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minutes.  
Table 3.2 Stoichiometry assay
a
 
Temp(°C) Molar ratio of 
PurE to PurK 
AIR(µM) ATP(µM) SAICAR(µM) 
37 1:1 17.9±0.7
b
 35.2±2.4 17.1±1.4 
50 1:1 17.7±0.4 38.1±6.6 17.7±1.8 
50 1:2 17.9±0.1 52.4±4.1 17.5±3.3 
a. Each assay was done in triplicate. b. AIR concentration was determined at 250nm 
(ε=3830 M
-1
cm
-1
, pH 7.0). 
When the molar ratio (monomer) of PurE to PurK was 1:1, the reaction showed the 
expected stoichiometry of 1:2:1 at 37 °C. Increasing the temperature to 50 °C gave the same 
result. Decreasing the concentration of PurE lead to a non-stoichiometric consumption of 
ATP, presumably because the nonenzymatic conversion of N
5
-CAIR to AIR was faster than 
the conversion of N
5
-CAIR. This indicates that the ratio of PurE to PurK is critical for 
preventing the waste of ATP at the expense of N
5
-CAIR synthesis. 
3.4.4 Protein-protein interaction 
  One mechanism by which N
5
-CAIR could be stabilized is by binding to PurK until PurE 
is available for catalysis. In addition, channeling between PurK and PurE could also occur. 
To examine this, we determined the rate of each enzyme in the presence of the other protein. 
Different monomer molar ratios (0.25, 0.5, 1 and 2) of these two proteins were mixed and 
either the AIR carboxylation or CAIR decarboxylation assays were conducted (rates shown 
in Figure 3.9).  
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(a) 
 
 
(b) 
 
 
(c) 
 
 
(d) 
 
 
Figure 3.9 The average rate (triplicate) for CAIR decarboxylation assay at 37°C (a) 
and 50°C (b), and AIR carboxylation assay at 37°C (c) and 50°C (d). 
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In the CAIR decarboxylation reaction for PurE, PurK was added in the mixture without its 
substrates, such as ATP and AIR. Therefore, PurK was inactive in this assay. The inactive 
PurK decreased the activity of PurE by 21% at 37 °C and 29% at 50 °C. The result suggests 
that PurK can regulate PurE; however, the mechanism by which this occurs is unknown. 
Repeating this assay in the presence of BSA resulted in no change. 
  For PurK, we utilized the AIR carboxylation reaction with PurE added in different molar 
ratios. In this assay, PurE was active since there was N
5
-CAIR produced by PurK. At 37 °C, 
the activity of PurK increased by 11% in the presence of PurE. And again, BSA had no 
change. This could suggest that the complex is formed. At 50 °C, the reaction showed the 
opposite result, the PurK activity decreased. We believe that the reason for this result at 
50 °C can be explained by the stoichiometry results. For the molar ratio of PurE to PurK at 0 
or 1:2, the reaction is nonstoichiometric and consumes more ATP because the N
5
-CAIR is 
decarboxylated back to AIR. As the amount of PurE increases, the N
5
-CAIR produced is 
converted to the more stable CAIR and thus the rate of ATP consumption decreases. 
  The protein-protein interaction study shows that the PurE and PurK from T. maritima can 
regulate each other. It suggests that these two enzymes probably form a protein complex.  
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4. Discussion 
4.1 Properties of PurE and PurK from T. maritima 
  The roles of PurK and PurE from E. coli have been studied by Meyer
6
 and Mueller
16
. 
Sequence comparisons of T. maritima with E. coli have indicated that T. maritima purE and 
purK genes are similar to those from E. coli, and the protein structure similarities with E. 
coli PurE and PurK have also been noted.
6,9,10,13,19
 We have studied the substrate specificity 
for PurK and PurE from T. maritima. T. maritima PurK was studied by the standard AIR 
carboxylation assay, which indicated that this enzyme utilized the same substrates as the 
enzyme from E. coli. Previous studies have shown that there are at least two classes of 
PurEs: N
5
-CAIR mutase and AIR carboxylase. To investigate PurE from T. maritima, we 
conducted a coupled assay with E. coli SAICAR synthetase in the absence or presence of 
PurK from T. maritima. In the absence of PurK, SAICAR synthesis was minimal indicating 
that T. maritima PurE was unable to catalyze the conversion of AIR into CAIR. However, in 
the presence of PurK, SAICAR synthesis was robust revealing that N
5
-CAIR was the 
substrate of T. maritima PurE. Both of these results indicate that T. maritima follows the 
same pathway previously determined for E. coli. 
  By studying the functions of PurK and PurE from T. maritima, we have shown that these 
enzymes have a functional similarity to the enzymes from E. coli. We have investigated the 
activity of these enzymes at different temperatures and have shown that they have higher 
activity at higher temperature. This is not surprising for an enzyme from a thermophilic 
organism. Thermal studies for other enzymes from thermophilic organisms have been 
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published.
21,22
 For example, in the study of S-adenosylhomocysteine hydrolase from T. 
maritima, the enzyme was most active at 75 °C.
22
 The enzyme also showed thermostability 
at 75 °C after incubating for 120 min. In another study, the thermostability of T. maritima 
dihydrofolate reductase was investigated by incubating the enzyme at high temperatures for 
15 min.
21 
The results showed that 100% of enzyme activity are retained at 75 °C while 65% 
remained at 90 °C. 
4.2 The problem with N
5
-CAIR 
Our studies on PurK and PurE from T. maritima indicate that this organism follow the 
same pathway for purine biosynthesis as E. coli. Such a result presents a potential problem. 
N
5
-CAIR is an unstable intermediate. The t1/2 of N
5
-CAIR at 37 °C is 1.3 min.
16
 The 
estimated t1/2 at 80 °C is about 80 ms. This rapid rate of decarboxylation suggests that 
N
5
-CAIR may not be a viable intermediate in purine biosynthesis. However, it is instructive 
to look at other unstable carbamates found in microbes. The compound 
N-carboxymethanofuran is an intermediate in the methanogenesis pathway found in 
methanogenic bacteria. A study of N-carboxymethanofuran shows that the t1/2 of this 
primary carbamate is 1 s at 17 °C and 88 ms at 37 °C in solution of pH 8.0.
23
 Thus, this 
critical compound is even more unstable than N
5
-CAIR, yet is still a key component is 
methanogenesis. 
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Figure 4.1 Structures of N5-CAIR and N-carboxymethanofuran.  
R1=ribose 5’-phosphate. R2=4-[N-(4,5,7-tricarboxyheptanoyl-γ-L-glutamyl-γ-L-glutamyl)- 
p-(β-aminoethyl) phenoxymethyl] 
 
The instability of N
5
-CAIR presents a challenge for de novo purine biosynthesis in T. 
maritima because ATP is consumed in the conversion of AIR to N
5
-CAIR. If N
5
-CAIR 
decomposes back to AIR, more ATP will be consumed. Thus, under certain conditions, a 
futile cycle can be created where the consumption of ATP is much greater than the synthesis 
of IMP from the pathway.  
In the study of the equilibrium of AIR and N
5
-CAIR, the results show that 30% of AIR is 
converted into N
5
-CAIR at 37 °C, but only 2% at 80 °C. The equilibrium and kinetic data 
clearly indicate that the amount of N
5
-CAIR present at 80 °C is low. Of course, the actual 
level of N
5
-CAIR would be dependent upon the concentration of CO2 in the bacteria as well 
as the temperature. 
Despite the challenge with N
5
-CAIR, the stoichiometry data at 50 °C showed that the 
reaction of AIR to SAICAR is stoichiometric with conditions in which the molar ratio of 
PurE and PurK are equal. However, when PurE is less than PurK, the reaction is not 
stoichiometric presumably due to the decomposition of N
5
-CAIR which leads to more ATP 
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consumption. In a stoichiometry study of C. neoformans ADE2, which is a bifunctional 
enzyme containing both PurE and PurK (thus both enzymes are locked into a 1:1 ratio), the 
reaction was stoichiometric.
14
 However, N
5
-CAIR was also released from the enzyme.
14
 
Studies on the E. coli PurK and PurE enzymes in a 1:1 ratio gave non-stoichiometric 
consumption of ATP.
14
  
In the pathway for the conversion of AIR to SAICAR, the concentration of N
5
-CAIR 
depends on the rate constants for PurK (k1), PurE (k2) and the decomposition rate k4 
(Scheme 4.1). There are two factors that affect the reaction rate: the activity of the enzymes 
and the quantity of enzymes in the reaction. In our stoichiometric studies, non-stoichiometry 
happened when the molar ratio of PurE/PurK is 1:2. Although PurE is highly active, the 
lower amount of PurE required a longer time to convert N
5
-CAIR to CAIR, which lead to 
the decomposition to AIR and thus more ATP consumption. A PurE/PurK complex could 
help to regulate these two enzymes in the pathway to prevent the wasteful decomposition of 
N
5
-CAIR by tightly controlling its synthesis and use. 
 
Scheme 4.1 Conversion of AIR to SAICAR. 
 
Our studies have revealed that the use of N
5
-CAIR as an intermediate is not a problem as 
long as the amount of monomer PurE and PurK are equal. The reason for this is unclear as it 
may be due simply to kinetics or it could be due to the nature of the function of a complex 
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between the PurE and PurK. 
4.3 Is there evidence for a protein-protein interaction between PurE and PurK? 
The challenge of N
5
-CAIR in the middle of the pathway could be dealt with by the 
formation of a PurK and PurE complex in which each enzyme is regulated by the other. Our 
studies have shown that the activities of either PurE or PurK are different when the other 
enzyme is present. Such a result indicates that PurE and PurK may form a complex which 
affects the kinetics of each enzyme.  
An example of a protein-protein interaction that regulates a metabolic function is 
imidazole glycerol phosphate (ImGP) synthase from T. maritima.
24
 ImGP synthase is a 
necessary enzyme which links histidine and de novo purine biosynthesis.
24
 It is a 
bifunctional enzyme complex, consisting of a glutaminase subunit (tHisH) and a synthase 
subunit (tHisF). tHisH produces ammonia which reacts with the unstable substrate, 
N’-((5’-phosphoribulosyl) formimino-5-aminoimidazole-4-ribo- nucleotide 
(PRFAR)(Scheme 4.2).
24
 Results of association state assays showed that tHisH and tHisF 
form a complex and enzyme kinetic assays for tHisF and the tHisH-tHisF complex showed 
that the kinetic constants of tHisF were affected in the presence of tHisH.
24
 The quaternary 
structure of the complex provided a hypothesis in which the protein-protein interaction 
forms a hydrophobic channel facilitating the transfer of ammonia from tHisH to tHisF for 
attack on PRFAR.  
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Scheme 4.2 The reaction of ImGP synthase (tHisH-tHisF). 
 
Another study on protein-protein interactions involving an unstable intermediate, 
carbamoyl phosphate (CP), in hyperthermophile Pyrococcus furiosus also has been done.
25
 
CP is produced by carbamoyl-phosphate synthetase (CKase) and is utilized by ornithine 
carbamoyltransferase (OTCase). The t1/2 of CP is about 5 min at 37 °C
26
, while at 100 °C, 
the optimal growth temperature of P. furious, the t1/2 is less than 2 s.
25
 The product of CP 
decomposition is cyanate, whose accumulation is harmful to the bacteria. A channeling 
cluster formed by CKase and OTCase was confirmed by two approaches including affinity 
electrophoresis and co-immunoprecipitate techniques.
25
 This channeling for CP is 
significant for the bacteria because it not only allows for an efficient reaction, but also 
protects the cells from cyanate. 
Organisms utilize dramatic approaches to overcome enormous challenges from both 
internal and external environments. The mechanism of PurE and PurK enzymes from T. 
maritima for dealing with the problem of the unstability of N
5
-CAIR is still not clear so far. 
Our studies provide a hint that an enzyme complex is probably formed. More evidence is 
required to confirm our hypothesis.  
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5. Future Study 
  To confirm our hypothesis in which PurE and PurK from T. maritima form a complex to 
stabilize N
5
-CAIR, techniques to determine a protein-protein interaction will be applied, 
such as chemical cross-linking, gel filtration or chromatography. The complex can also be 
determined by CD spectroscopy. 
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De novo purine biosynthesis is divergent depending upon the organism. In bacteria, yeasts 
and plants, 5-aminoimidazole ribonucleotide (AIR) is converted to 
4-carboxyaminoimidazole ribonucleotide (CAIR) by N
5
-carboxyaminoimidazole 
ribonucleotide (N
5
-CAIR) synthetase (PurK) and N
5
-CAIR mutase (Class I PurE). In 
animals, AIR is converted into CAIR by AIR carboxylase (Class II PurE). The distinction 
makes PurK and Class I PurE good targets in design of antimicrobial drugs. N
5
-CAIR is 
chemically unstable with t1/2 of about 0.9 minutes at pH 7.8 and 37 °C. If the production of 
N
5
-CAIR is not regulated relative to its conversion to CAIR, ATP utilization can rapidly 
become non-stoichiometric. One mechanism to study this problem is to investigate how the 
problem is dealt with under conditions in which N
5
-CAIR is even more unstable, such as at 
higher temperature. Thermotoga maritima, originally isolated from geothermal heated 
marine sediment, is a thermophilic bacterium whose optimal growth temperature is 80°C. 
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The TM0446 and TM0447 genes of Thermotoga maritima encode a 
phosphoribosylaminoimidazole mutase (PurE) and synthetase (PurK) individually. We 
cloned genes and expressed both proteins. Enzyme kinetic analyses for each enzyme 
indicate that these enzymes follow the same pathway as those found in E. coli. Studies of 
the stoichiometry of the reaction reveal that at elevated temperature, the reactions are 
stoichiometric as long as the ratio of PurE and PurK is 1:1. When this ratio is lower, ATP 
consumption becomes non-stoichiometric. We have also examined whether there is a 
complex formed between these enzymes. Our data indicate that each enzyme is capable of 
regulating the activity of the other. This suggests that a complex is formed by these two 
enzymes. 
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